SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000921895-20-002483
Filing Date
2020-09-28
Accepted
2020-09-28 16:40:31
Documents
4

Document Format Files

Seq Description Document Type Size
1 sc13d12566zan_09282020.htm SC 13D 115627
2 ex991to13d12566zan_09282020.htm EX-99.1 70863
3 ex992to13d12566zan_09282020.htm EX-99.2 71265
4 ex993to13d12566zan_09282020.htm EX-99.3 4405
  Complete submission text file 0000921895-20-002483.txt   263621
Mailing Address MAKY ZANGANEH & ASSOCIATES 2087 SHARON ROAD MENLO PARK CA 94025
Business Address
Zanganeh Maky (Filed by) CIK: 0001507650 (see all company filings)

Type: SC 13D

Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-514-7149
Summit Therapeutics Inc. (Subject) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88759 | Film No.: 201204832
SIC: 2834 Pharmaceutical Preparations